Latest News
Press Releases
November 30, 2021
GreenLight Biosciences (ENVI) partners with IAVI to accelerate COVID-19 vaccine trial in Africa
October 27, 2021IAVI and the Biomedical Advanced Research and Development Authority partner to advance filovirus vaccine candidates
July 14, 2021Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials
June 15, 2021EDCTP and CEPI funding moves IAVI’s Lassa fever vaccine candidate into advanced clinical development
February 3, 2021First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research
Features
November 10, 2021
Enabling the next generation of science leaders
October 20, 2021TB survivors from G20 countries call upon their leaders to invest $1 billion per year to develop new TB vaccines
October 18, 2021Vaccines Security in Africa – Which Way Next?
September 30, 2021IAVI applauds Biden Administration’s intent to nominate John Nkengasong as head of PEPFAR
September 1, 2021IAVI statement on results from Phase IIb Imbokodo HIV vaccine clinical trial
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
